SHL Telemedicine Ltd: Appointment of interim acting Managing Director in Germany Dienstag, 21. Mai 2019 - 07:00

Press Release

Tel Aviv / Zurich, 21 May 2019 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) (“SHL”), a leading provider and developer of advanced personal telemedicine solutions, announced today the appointment of Ralf Bork as interim acting Managing Director of SHL Germany.

Ralf Bork will take over from Martin Lehner who will be departing at the end of May, 2019. Ralf Bork has significant experience in the German healthcare market and has held the positions of Head of International Development and Deployment at Allianz Global Health Munich and VP Commercial at ResMed Healthcare Germany. He has been serving as VP Telehealth Solutions of SHL Germany since February 2018.

For further information, please contact:

Martin Meier-Pfister, IRF, phone +41 43 244 81 40, shl@irf-reputation.ch

About SHL Telemedicine

SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call centre services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957). For more information, please visit the web site at www.shl-telemedicine.com.

Some of the information contained in this press release contains forward-looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. SHL Telemedicine undertakes no obligation to publicly update or revise any forward-looking statements.